For many, these price reductions may represent a critical step in improving access to essential medications, especially as ...

Several common drugs will be cheaper next year under Medicare, from weight-loss drug Ozempic to breast-cancer medication ...

Indiana University School of Medicine researchers are taking a closer look at how young patients respond to biologic ...

The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.

The MHRA has approved depemokimab as an add-on treatment for severe asthma and chronic rhinosinusitis with nasal polyps.

Povorcitinib is a selective oral small-molecule JAK1 inhibitor, with compound and use patents in certain countries/regions in the Territory. Currently, povorcitinib is in Phase 3 clinical trials for ...

Medicare beneficiaries will see major pricing shifts as federal negotiations reshape how costly prescription drugs are paid ...

The Trump administration has negotiated lower prices for 15 widely used medications covered by Medicare, with the federal government saying the effort will cut spending on those drugs by 44%, or about ...

Asthma flares can strike when allergens are high or after an illness, and many people with the condition want to know how they can manage symptoms and when to adjust medications. Asthma flares can ...

Asthma flares can strike when allergens are high or after an illness, and many people with the condition want to know how they can manage symptoms and when to adjust medications. A News 9 viewer says ...